Search
Aidi Pharmaceutical: Ainuomiti Tablet Secures Drug Registration in Zanzibar
6 day ago /
Read about 0 minute
Author：小编
Aidi Pharmaceutical has achieved a significant milestone with the Zanzibar Food and Drug Administration granting a drug registration certificate to its self-developed Ainuomiti Tablet. This class 1 new drug, formulated as a triple single-tablet regimen for HIV-1 infection, marks Aidi Pharmaceutical's inaugural overseas registration and launch. This accomplishment signifies a pivotal breakthrough in the company's efforts to internationalize its innovative anti-HIV drug portfolio, paving the way for expanded overseas market presence and enhanced product sales revenue.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
